tiprankstipranks
Trending News
More News >
Mereo Biopharma Group Plc (MREO)
NASDAQ:MREO
US Market

Mereo Biopharma Group Plc (MREO) Income Statement

Compare
708 Followers

Mereo Biopharma Group Plc Income Statement

Last quarter (Q3 2025), Mereo Biopharma Group Plc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Mereo Biopharma Group Plc's net income was $-7.02M. See Mereo Biopharma Group Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 10.00M$ 0.00$ 49.21M$ 0.00
Gross Profit
$ 0.00$ 7.43M$ 257.44K$ 25.04M$ -2.05M
Operating Expenses
$ 47.36M$ 35.84M$ 53.92M$ 53.30M$ 46.13M
Depreciation and Amortization
$ 1.09M$ 1.06M$ 895.50K$ 866.47K$ 2.05M
EBITDA
$ -40.80M$ -26.06M$ -39.98M$ 25.49M$ -203.41M
Operating Income
$ -47.36M$ -28.42M$ -53.67M-$ -48.18M
Other Income/Expenses
$ 4.11M$ -1.58M$ 9.21M$ 47.48M$ -165.27M
Pretax Income
$ -43.25M$ -30.00M$ -44.46M$ 19.22M$ -213.45M
Net Income
$ -43.25M$ -29.47M$ -42.12M$ 17.17M$ -209.83M
Per Share Metrics
Basic EPS
$ -0.29$ -1.10K$ -1.75K$ 749.65$ -16.50K
Diluted EPS
$ -0.29$ -1.10K$ -1.75K$ 749.65$ -16.50K
Weighted Average Shares Outstanding
147.92M 131.89M 120.64M 116.73M 67.79M
Weighted Average Shares Outstanding (Diluted)
147.92M 131.89M 120.64M 116.73M 67.79M
Currency in USD

Mereo Biopharma Group Plc Earnings and Revenue History